The sociodemographic characteristics of PSS patients and the control group.
characteristics | Patients | Control | P-value |
---|---|---|---|
n (%) | |||
Sex | |||
Female | 31 (96.90) | 29 (96.70) | inevaluable |
Male | 1 (3.10) | 1 (3.30) | |
Age | |||
n | 32 | 30 | 0.21 |
% mean±SD | 45.84±9.39 | 42.8±9.52 | |
median (min-max) | 46 (24-63) | 42 (28-64) | |
Education n (%) | |||
5-8 years | 22 (68.80) | 20 (66.70) | 0.861 |
>8 years | 10 (31.30) | 10 (33.30) | |
Disease duration | 32 | ||
% mean±SD | 3.45±3.75 | ||
median (min-max) | 2.25 (0.25-18) | ||
SS-A positive | 21 (67.70) | ||
SS-B positive | 3 (9.70) | ||
RO52 positive | 16 (51.60) | ||
Drugs | |||
Hydroxichloroqine | 29 (90.6) | ||
Pilocarpine | 16 (50.0) | ||
*NSAİD | 11 (34.4) | ||
Prednisolone | 4 (12.5) | ||
**other | 8 (25) | ||
***comorbidity | 9 (28) |